Full-Time

Clinical Trial Manager

Posted on 8/23/2024

Tango Therapeutics

Tango Therapeutics

51-200 employees

Develops targeted cancer therapies using synthetic lethality

Biotechnology
Healthcare

Senior

Boston, MA, USA

Category
Healthcare Administration & Support
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree in life science or allied health field (e.g. nursing, medical or laboratory technology)
  • At least 5 years’ experience in trial operations, mostly within industry
  • Excellent written and oral communication skills
  • Strong working knowledge of GCP/ICH and other applicable regulations/guidelines
  • Good organizational/prioritization skills with strong attention to detail
  • Proficiency with MS Office: Outlook, Word, Excel, PowerPoint, MS Project, and SharePoint
  • Ability to work collaboratively with cross-functional teams and partners
Responsibilities
  • You will manage clinical trials from start-up through close-out to ensure both internal and external deliverables are on time and on budget while facilitating collaboration across functional areas
  • Work with the cross functional clinical team to coordinate the relevant and timely exchange of information/materials to support clinical trial delivery and execution
  • Oversee and contribute to the development of clinical trial project timelines and ensure communication and understanding of risks/challenges; establish plans and monitor metrics; ensure that timelines are accurate and comprehensive
  • Proactively manage clinical trial outsourced partners, including identification of risk, to ensure trial deliverables and performance goals are met
  • Manage the day-to-day contact with CRO counterpart; daily review and identification of potential issues or problems with sites and communicate/escalate to clinical team as necessary
  • Collaborate with CRO to keep clinical study database current and accurate
  • Proactively manage and track project scope and change orders, for clinical trial operations
  • Additional duties and responsibilities as required

Tango Therapeutics develops targeted cancer treatments using the principle of synthetic lethality, which allows them to design drugs that kill cancer cells while leaving healthy cells unharmed. Their approach focuses on the interaction between genes, where the loss of both genes leads to cell death, but the loss of just one does not. This method enables them to create more effective therapies for cancer patients. Tango operates in the oncology market, primarily serving healthcare providers and pharmaceutical companies interested in advanced cancer therapies. They collaborate with larger pharmaceutical firms, like Gilead Sciences, to co-develop their treatments, which helps them secure funding and speed up the development process. Tango's goal is to bring next-generation targeted immunotherapies to market, supported by a strong team and strategic partnerships.

Company Stage

IPO

Total Funding

$341.4M

Headquarters

Cambridge, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

1%

1 year growth

3%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing interest in synthetic lethality enhances Tango's innovative approach in oncology.
  • Recent $80 million financing strengthens Tango's financial position for future developments.
  • FDA clearance for TNG348 and TNG462 boosts Tango's clinical trial advancements.

What critics are saying

  • Discontinuation of TNG348 due to liver toxicity may affect investor confidence.
  • Reliance on partnerships for financial support poses risks if partnerships change.
  • Intensifying competition in precision oncology could impact Tango's market share.

What makes Tango Therapeutics unique

  • Tango leverages synthetic lethality to target cancer cells while sparing healthy ones.
  • Their focus includes counteracting tumor suppressor gene loss and immune evasion.
  • Strategic collaborations with pharma companies accelerate development and commercialization of therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

INACTIVE